Data were analyzed using TIBCO Statistica software (v
It scientifically regulates insulin secretion, suppresses glucagon, delays gastric emptying, and assists in controlling blood sugar levels, thereby promoting healthy fat reduction and optimizing overall health management
However, variability in GI physiology and safety constraints limit universal success
In the same trial, 1-8% of patients reported injection site reactions with retatrutide, while no case was reported in the placebo group
And I think they will continue to do well as more people use GLP-1 drugs as one of the most common reported side effects is gastrointestinal distress. He added: My advice for a lot of brands wondering how to respond to new trends such as GLP-1s is instead of chasing them with new products, look at where your existing products can be positioned to tap into them
Neither medication is automatically better for everyone